Preventive Effects of Hyaluronic Acid on Escherichia coli-induced Urinary Tract Infection in Rat

Urology

Volumn 75, Issue 4, 2010, Pages 949-954

  Lee, Dong Gi ^a   Cho, Jeong Je ^a   Park, Hun Kuk ^a   Kim, Dae Kyung ^b   Kim, Jin Il ^a   Chang, Sung Goo ^a   Lee, Sun Ju ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Eulji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL GROWTH; CONTROLLED STUDY; CYSTITIS; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; INOCULATION; MICTURITION; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; URINARY TRACT INFECTION; UROTHELIUM;

ANIMALS; ESCHERICHIA COLI INFECTIONS; FEMALE; HYALURONIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 77950299678     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.047     Document Type: Article

References (15)

1. Foxman B., Barlow R., D'Arcy H., et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10 (2000) 509-515
2. Foxman B., Gillespie B., Koopman J., et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 151 (2000) 1194-1205
3. Avorn J., Monane M., Gurwitz J.H., et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. J Am Med Assoc 271 (1994) 751-754
4. Raz R., and Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329 (1993) 753-756
5. Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65 (1999) 3763-3766
6. Schulman C.C., Corbusier A., Michiels H., et al. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150 (1993) 917-921
7. Kruze D., Holzbecher K., Andrial M., et al. Urinary antibody response after immunisation with a vaccine against urinary tract infection. Urol Res 17 (1989) 361-366
8. Poggi M.M., Johnstone P.A., and Conner R.J. Glycosaminoglycan content of human bladders: a method of analysis using coldcup biopsies. Urol Oncol 5 (2000) 234-237
9. Boucher W.S., Letourneau R., Huang M., et al. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 167 (2002) 380-384
10. Oberpenning F., van Ophoven A., and Hertle L. Interstitial cystitis: an update. Curr Opin Urol 12 (2002) 321-332
11. Bouchelouche K., and Nordling J. Recent developments in the management of interstitial cystitis. Curr Opin Urol 13 (2003) 309-313
12. Constantinides C., Manousakas T., Nikolopoulos P., et al. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 93 (2004) 1262-1266
13. Lipovac M., Kurz C., Reithmayr F., et al. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynecol Obstet 96 (2006) 192-195
14. Yi J.W., and Lee S.J. Effects of hyaluronic acid in rats with cyclophosphamide induced cystitis. Korean J Urol 46 suppl 2 (2005) 158 Abstract:83
15. Takahashi K., Takeuchi J., Takahashi T., et al. Effects of sodium hyaluronate on epithelial healing of the vesical mucosa and vesical fibrosis in rabbits with acetic acid induced cystitis. J Urol 166 (2001) 710-713